All opportunities
Publicly Advertised Opportunity
Hybrid
Vice President / Executive Leadership
Biotechnology / Biopharmaceuticals / Pharmaceutical Research

Vice President, Global Pharmacovigilance & Patient Safety

Employer
Jazz Pharmaceuticals plc
Industry
Biotechnology / Biopharmaceuticals / Pharmaceutical Research
Location
Waltham, Massachusetts, United States
Country
United States
Work arrangement
Hybrid
Seniority
Vice President / Executive Leadership
Department
Global Pharmacovigilance & Patient Safety
Application status
Accepting applications
Closing date
2026-11-30
Closes in–d –h –m –s· Monday, 30 November 2026 at 19:14 (UTC)

Your application is received by Westbridge for review. We do not automatically forward materials to an employer.

About the role

The Vice President, Global Pharmacovigilance & Patient Safety will lead the development and execution of global drug safety strategy, ensuring effective safety surveillance throughout clinical development and commercial product lifecycles.

The successful executive will strengthen pharmacovigilance infrastructure, oversee international regulatory interactions, establish consistent safety governance, and support the organization's expanding neuroscience and oncology portfolio.

The role also includes executive-level engagement with regulatory authorities and cross-functional leadership teams.

Company overview

Jazz Pharmaceuticals plc is identified in the source mandate as a specialty biotechnology and biopharmaceutical company headquartered in Dublin, Ireland, with its U.S. operational hub in Waltham, Massachusetts.

Further company information should be independently verified before publication.

Key responsibilities

Define and execute global pharmacovigilance strategy, policies, and operational standards.

Direct safety signal management, aggregate safety reporting, and signal evaluation procedures.

Oversee risk management planning, including RMPs and REMS, and continuous benefit-risk evaluation.

Represent the organization in senior-level pharmacovigilance discussions with international regulatory agencies.

Provide strategic safety input into clinical trial designs, investigator brochures, protocols, and regulatory submissions.

Lead global safety governance and chair the Executive Safety Oversight Committee.

Oversee pharmacovigilance budgets, vendor contracts, systems infrastructure, and functional staffing.

Strengthen global CRO partnerships and safety processing operations.

Ensure regulatory compliance across FDA, EMA, PMDA, and MHRA requirements.

Candidate profile

The ideal candidate will be an established pharmaceutical or biopharmaceutical safety executive with substantial experience leading global pharmacovigilance operations, regulatory safety strategy, and enterprise-level patient safety functions.

The individual should demonstrate the ability to lead multidisciplinary international teams, manage complex safety decisions, and communicate effectively with executive leadership and regulatory authorities.

Required qualifications

M.D. degree or equivalent broad medical qualification.

At least 12 years of progressive leadership experience in biopharmaceutical pharmacovigilance and drug safety.

Experience directing both pre-approval clinical trial safety and post-marketing pharmacovigilance operations.

Proven experience managing global regulatory health authority interactions, safety negotiations, and audits.

Demonstrated experience leading enterprise drug safety committees and cross-functional risk evaluation teams.

Preferred qualifications

Direct therapeutic experience in neuroscience, sleep medicine, or targeted oncology.

Experience integrating pharmacovigilance infrastructure following mergers and acquisitions, asset licensing, or major corporate transactions.

Demonstrated ability to lead organizational transformation and international safety governance.

Compensation & benefits

The source mandate provides the following estimated compensation framework:

Estimated annual base salary: $380,000–$420,000.

Annual performance bonus: Target of 35%–40% of base salary.

Long-term incentives/equity: Estimated annual grant value of $350,000–$500,000.

Estimated total initial compensation package: $550,000–$700,000+.

Additional executive benefits package.

Important: These figures are estimates contained in the confidential mandate, not independently verified or confirmed employer-approved compensation. Do not enter them into fields designated for verified salary figures.

Work arrangements

Arrangement: Hybrid

Location: Waltham, Massachusetts, United States

Primary location: Waltham, Massachusetts, United States.

Working arrangement: Hybrid.

Office attendance: 2–3 days per week on-site.

Travel: Approximately 15%–20% domestic and international travel.

Geographical scope: North America, Europe, and Asia-Pacific.

Relocation arrangements: Not specified.

Eligible remote-working locations: Not specified.

Reporting structure

Reporting line: Executive Vice President, Chief Medical Officer (CMO)

Department: Global Pharmacovigilance & Patient Safety

Application instructions

Interested candidates should submit their professional interest and relevant career information through the designated Westbridge Search application channel. All expressions of interest and candidate evaluations are to be coordinated through the designated Westbridge representative, subject to confirmation of the authorized application process.

Independent analysis

This is a senior global pharmacovigilance leadership appointment requiring substantial medical, regulatory, and operational expertise. The strongest candidates will have: Extensive global drug safety leadership experience. An M.D. or equivalent medical qualification. Strong FDA, EMA, PMDA, and MHRA regulatory experience. Leadership of large international pharmacovigilance teams. Experience overseeing both clinical development safety and commercial product safety. Expertise in neuroscience, oncology, or complex therapeutic portfolios. The most significant leadership challenge will be scaling global pharmacovigilance operations while maintaining regulatory compliance, effective safety governance, and uninterrupted late-stage clinical development.

Interested in this role?

Westbridge reviews role enquiries and responds with relevant information about the opportunity and its application process.

Ask about this role →

More opportunities

Loading roles…